Literature DB >> 9053835

Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound.

Y Sun1, J Bian, Y Wang, C Jacobs.   

Abstract

p53, a tumor suppressor gene, functioning as a transcription factor, has been recently shown in a cell free system to be subject to redox (reduction/oxidation) regulation. Oxidants or metal chelating reagents disrupt wildtype p53 conformation and decrease or abolish its DNA binding activity, while reductants restore wildtype conformation and increase DNA binding. We have extended these observations to intact cell systems by using luciferase transactivation assay in two murine tumor cell lines, both harboring endogenous wildtype p53. The results showed that none of these in vitro active reagents, except 1,10-phenanthroline (OP) has a significant effect on p53 transactivation activity. OP, a metal chelator and p53 inactivator in cell free systems, however, induces p53 transactivation activity as well as sequence-specific DNA binding in a dose dependent manner. OP also differentially induces endogenous expression of several known p53 target genes such as Waf-1 and Mdm-2, but not Bax, Gadd45, and PCNA. Increased p53 activity induced by OP is not due to elevated p53 mRNA nor to protein levels. Furthermore, the OP-induced p53 transcriptional activation is not due to its potential DNA intercalating activity, but mainly due to its metal chelating activity. OP was also found to induce dramatically apoptotic cell death in these tumor cells harboring wildtype p53, to a less extent in MEF cells from p53 knockout mice and not at all in Saos-2 cells without p53 or Rb. We concluded from this study that (a) unlike what has been seen in vitro, OP induces p53 activity in intact cells (b) OP activates p53 transcriptional activity without increasing p53 protein; and (c) activation of p53 may contribute to apoptosis, but is not required.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9053835     DOI: 10.1038/sj.onc.1200834

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.

Authors:  J Bian; Y Sun
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Authors:  Jun Li; Mingjia Tan; Ling Li; Deepika Pamarthy; Theodore S Lawrence; Yi Sun
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

4.  Histone hypoacetylation is involved in 1,10-phenanthroline-Cu2+-induced human hepatoma cell apoptosis.

Authors:  Jiuhong Kang; Jie Chen; Yufeng Shi; Jie Jia; Zhenhua Wang
Journal:  J Biol Inorg Chem       Date:  2005-01-27       Impact factor: 3.358

5.  Regulation of Mdm2-directed degradation by the C terminus of p53.

Authors:  M H Kubbutat; R L Ludwig; M Ashcroft; K H Vousden
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

6.  SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents.

Authors:  H Duan; Y Wang; M Aviram; M Swaroop; J A Loo; J Bian; Y Tian; T Mueller; C L Bisgaier; Y Sun
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?

Authors:  J Bian; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis.

Authors:  X Xu; D Yang; T Wyss-Coray; J Yan; L Gan; Y Sun; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

Authors:  P Heffeter; A Popovic-Bijelic; P Saiko; R Dornetshuber; U Jungwirth; N Voevodskaya; D Biglino; M A Jakupec; L Elbling; M Micksche; T Szekeres; B K Keppler; A Gräslund; W Berger
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

10.  Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  Siddhesh Aras; Gyanendra Singh; Kenneth Johnston; Timothy Foster; Ashok Aiyar
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.